Amevive (Biogen Inc.)
Amevive (Biogen Inc.) Brand names, Amevive (Biogen Inc.) Analogs
Amevive (Biogen Inc.) Brand Names Mixture
- No information avaliable
Amevive (Biogen Inc.) Chemical_Formula
C2306H3594N610O694S26
Amevive (Biogen Inc.) RX_link
http://www.rxlist.com/cgi/generic3/amevive.htm
Amevive (Biogen Inc.) fda sheet
Amevive (Biogen Inc.) msds (material safety sheet)
Amevive (Biogen Inc.) Synthesis Reference
No information avaliable
Amevive (Biogen Inc.) Molecular Weight
51801.1
Amevive (Biogen Inc.) Melting Point
No information avaliable
Amevive (Biogen Inc.) H2O Solubility
No information avaliable
Amevive (Biogen Inc.) State
Liquid
Amevive (Biogen Inc.) LogP
-0.432
Amevive (Biogen Inc.) Dosage Forms
Powder for solution
Amevive (Biogen Inc.) Indication
For treatment of moderate to severe chronic plaque psoriasis
Amevive (Biogen Inc.) Pharmacology
Interferes with lymphocyte activation by specifically binding to the lymphocyte antigen, CD2, and inhibiting LFA-3/CD2 interaction. Activation of T lymphocytes involving the interaction between LFA-3 on antigen-presenting cells and CD2 on T lymphocytes plays a role in the pathophysiology of chronic plaque psoriasis. Also causes a reduction in subsets of CD2+ T lymphocytes as well as CD4+ and CD8+ T lymphocytes.
Amevive (Biogen Inc.) Absorption
No information avaliable
Amevive (Biogen Inc.) side effects and Toxicity
No information avaliable
Amevive (Biogen Inc.) Patient Information
BIOD00055.html
Amevive (Biogen Inc.) Organisms Affected
Humans and other mammals
